Showing results (81-90 of 111) with videos related to
Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumorsMichael J Morris, Neeta Pandit-Taskar, Chaitanya R Divgi, et al.Annals of Surgery|April 1, 2008
Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastasesAnne M Covey, Karen T Brown, William R Jarnagin, et al.Cancer|April 28, 2004
High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinomaMichael J Morris, Oren Smaletz, David Solit, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2006
Phase II study of sorafenib in patients with advanced hepatocellular carcinomaGhassan K Abou-Alfa, Lawrence Schwartz, Sergio Ricci, et al.EJNMMI Research|May 19, 2015
Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumorsNeeta Pandit-Taskar, Joseph A O'Donoghue, Chaitanya R Divgi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2005
Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistryKi Young Chung, Jinru Shia, Nancy E Kemeny, et al.European Radiology|June 6, 2020
Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter studyHiram Shaish, Andrew Aukerman, Rami Vanguri, et al.The Journal of Investigative Dermatology|November 4, 2018
Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult PopulationZelma C Chiesa Fuxench, Julie K Block, Mark Boguniewicz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2005
Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignanciesOwen A O'Connor, Mark L Heaney, Lawrence Schwartz, et al.Annals of Surgical Oncology|July 4, 2012
Ki-67 is a prognostic biomarker of survival after radiofrequency ablation of liver malignanciesConstantinos T Sofocleous, Sandeep Garg, Lydia M Petrovic, et al.Pageof 12